Acute leukemias (both myeloid and lymphoblastic) are a group of diseases for which each
year more successful therapies are implemented. However, in a subset of cases the overall …

Diagnosis and classification of acute myeloid leukaemia (AML) require cytogenetic and
molecular genetic investigation. However, while these evaluations are pending, morphology …

Acute myeloid leukaemia (AML) is a heterogenous disease. Prognosis of AML is influenced
both by patient‐specific as well as disease‐specific factors. Age is the most prominent …

Mixed-phenotype acute leukemia (MPAL) is a heterogeneous category in the World Health
Organization classification that comprises acute leukemias with discrete admixed …

In recent decades, therapy for acute myeloid leukemia (AML) has remained relatively
unchanged, with chemotherapy regimens primarily consisting of an induction regimen …

Despite diagnostic criteria are currently available for the distinct subtypes of monocytic‐
lineage neoplasias, a number of partially overlapping features still remain evident, which …

The role of the vascular microenvironment is increasingly studied in acute myeloid
leukaemia (AML). Complex interactions between endothelial cells (ECs) and pre-leukaemic …

Acute myeloid leukemia (AML) is a myeloid malignancy that is characterized by the
accumulation of leukemic blast cells, which originate from hematopoietic stem cells that …

Background: The aim of this review was to evaluate the influence of aberrant phenotypes in
prognosis and survival in acute myeloid leukemia (AML) patients by multiparametric flow …

Background Elevated protein expressions of CD markers such as IL2RA/CD25,
CXCR4/CD184, CD34 and CD56 are associated with adverse prognosis in acute myeloid …